CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Certified by Founder
Lodge
causaLens
start up
United Kingdom
- London, England
- 28/01/2022
- Series A
- $45,000,000
causaLens are the pioneers of Causal AI — a giant leap in machine intelligence.
We build Causal AI-powered products that are trusted by leading organizations across a wide range of industries. Our No-Code Causal AI Platform empowers all types of users to make superior decisions through an intuitive user interface. We are creating a world in which humans can trust machines with the greatest challenges in the economy, society and healthcare.
For more information visit www.causaLens.com or contact us on info@causaLens.com.
- Industry Software Development
- Website https://www.causalens.com/
- LinkedIn https://www.linkedin.com/company/causalens/
Related People
Darko Matovski, PhDCo Founder
United Kingdom -
London, England
We are creating a world in which humans can trust machines with the greatest challenges in the economy, society and healthcare.
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)